Navigation Links
Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology
Date:1/6/2009

NEW ROCHELLE, N.Y., Jan. 6 /PRNewswire/ -- Dedicated to the memory and scientific accomplishments of Dr. Judah Folkman, who pioneered the fields of angiogenesis and vasculogenesis and shed light on the link between blood supply and neoplastic disease, the newly released special double issue (Volume 6, Number 3-4) of Lymphatic Research and Biology includes a series of papers that reflect the research impact of one of the pre-eminent physician-scientists of his generation. Lymphatic Research and Biology is a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The issue is available free online at www.liebertpub.com/lrb

"Not only did Judah Folkman single-handedly create the research discipline of angiogenesis, he also played a very fundamental role in the extension of the same principles to the field of lymphangiogenesis research," says Stanley G. Rockson, MD, Editor-in-Chief of the Journal and Chair of the Scientific Advisory Board of the Lymphatic Research Foundation. Dr. Rockson, who is the Chief of Consultative Cardiology, the Allan and Tina Neill Professor of Lymphatic Research and Medicine, and Director of the Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, feels that "his impact as a teacher and mentor is almost incalculable, and we are proud to present these contributions by leading scientists whose training and career path directly reflect the impact of Dr. Folkman's work and teaching."

Leah Cueni and Michael Detmar provide an in-depth review of the field in "The Lymphatic System in Health and Disease," and Carrie Shawber and Jan Kitajewski describe "Arterial Regulators Taken Up by Lymphatics." In the paper "Why and How Do Tumors Stimulate Lymphangiogenesis?," Yihai Cao explains the processes behind increased lymphatic supply to cancerous lesions. Dean Felsher explores the phenomena of oncogene addiction, cellular senescence, and the angiogenic switch in a report entitled, "Reversing Cancer From Inside and Out." In a forward-looking review, Steven Stacker and Marc Achen present "From Anti-Angiogenesis to Anti-Lymphangiogenesis: Emerging Trends in Cancer Therapy." A report by Michael Mancuso, Frank Kuhnert, and Calvin Kuo focuses on "Developmental Angiogenesis of the Central Nervous System."

Lymphatic Research and Biology is an authoritative peer-reviewed journal published quarterly in print and online. As the official journal of the Lymphatic Research Foundation, it provides an interdisciplinary forum for the world's leading biomedical investigators to discuss current and anticipated developments in lymphatic biology and pathology. Original research derives from a variety of investigative disciplines, including genetics, biochemistry and biophysics, cellular and molecular biology, physiology and pharmacology, anatomy, developmental biology, and pathology. A complete table of contents and free sample issue may be viewed online at www.liebertpub.com/lrb

Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at www.liebertpub.com

    Mary Ann Liebert, Inc.
    140 Huguenot St., New Rochelle, NY 10801-5215
    Phone: (914) 740-2100    
    (800) M-LIEBERT
    Fax:  (914) 740-2101
    www.liebertpub.com

Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2156, vcohn@liebertpub.com


'/>"/>
SOURCE Mary Ann Liebert, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. New Edition of Definitive Resource in Tissue Engineering Released Today
3. BioMS Medical announces its intention to renew a normal course issuer bid
4. Pressure BioSciences, Inc. Issued First Patent in Canada
5. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
6. Pharmos Issues Letter to Shareholders
7. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
8. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
9. HHS Issues First Department-Wide Report on Personalized Health Care
10. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
11. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):